The role of proinflammatory cytokines in the development of chronic discogenic pain syndrome
https://doi.org/10.25789/YMJ.2023.84.30
Abstract
The purpose of this review is to update the knowledge of neurologist doctors about the role of pro-inflammatory cytokines in the evelopment and chronicity of discogenic pain syndrome in patients with intervertebral disc degeneration.
About the Authors
A. V. Ashkhotov
V.M. Bekhterev Institute of Personalized Psychiatry and Neurology SMRC PN
Russian Federation
Russian Federation
Ashkhotov Azamat Vyacheslavovich – neurologist-researcher
St. Petersburg
N. A. Shnaider
V.M. Bekhterev Institute of Personalized Psychiatry and Neurology SMRC PN
Russian Federation
Russian Federation
Shnaider Natalya Alekseevna – Doctor of Medical Sciences, Prof., Chief Researcher
St. Petersburg
V. V. Trefilova
V.M. Bekhterev Institute of Personalized Psychiatry and Neurology SMRC PN
Russian Federation
Russian Federation
Trefilova Vera Vasilievna – graduate student
M. A. Novitsky
Center for Collective Use Molecular and Cellular Technologies, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Novitsky Maxim Aleksandrovich – neurologist
Krasnoyarsk
M. M. Petrova
Center for Collective Use Molecular and Cellular Technologies, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Petrova Marina Mikhailovna – Doctor of Medical Sciences, Prof.
R. F. Nasyrova
Hospital for War Veterans
Russian Federation
Russian Federation
Nasyrova Regina Faritovna – Doctor of Medical Sciences, Chief Researcher, Department of Neurology
St. Petersburg
References
1. Degenerative-dystrophic diseases of the spine / Lutsik A.A., Sadova, M.A., Krutko A.V. [et al.]. Clinical recommendations of the All-Russian public organization ‘Association of Traumatologists and Orthopedists of Russia’ (ATOR). Novosibirsk; 2012:264.2.
2. Sorokin Yu.N. Back Pain and Intervertebral Disc Degeneration in the International Classification of Diseases 11th Revision / S. Korsakov Journal of Neurology and Psychiatry 2019; 119(8): 153 159 (https://doi.org/10.17116/ineuro2019119081153.3.
3. Cabal-Hierro L., Lazo P.S. Signal transduction by tumor necrosis factor receptors. Cell Signal 2012;24:1297–1305. doi: 10.1016/j.cellsig.2012.02.006.
4. Patil P., Niedernhofer L.J., Robbins P.D. [et al.] Cellular senescence in intervertebral disc aging and degeneration. Curr Mol Biol Rep. 2018;4(4): 180–190. doi: 10.1007/s40610-018-0108-8.
5. Cua D.J., Tato C.M. / Innate IL-17-producing cells: The sentinels of the immune system. Nat. Rev. Immunol. 2010;10:479–489. doi: 10.1038/nri2800.
6. Shneider N.A., Ashhotov A.V., Trefilova V.V. [et al.] Cytokine imbalance as a biomarker of inter-vertebral disk degeneration. Cytokine imbalance as a biomarker of intervertebral disk degeneration. Int J Mol Sci. 2023;24(3):2360. doi: 10.3390/ijms24032360.
7. Shneider N.A., Khasanova A.K., Strelnik A.I. [et al.] Cytokine imbalance as a biomarker of thera-peutic resistance to antipsychotics. Int. J. Mol. Sci. 2022; 23:x. https://doi.org/10.3390/xxxxx.
8. Likhitpanichkul M., Torre O.M., Gruen J. [et al.]. Do mechanical strain and TNF-α interact to amplify pro-inflammatory cytokine production in human annulus fibrosus cells? J. Biomech. 2016;49: 1214–1220. doi: 10.1016/j.jbiomech.2016.02.029.
9. Dudli S., Haschtmann D., Ferguson S.J. Fracture of the vertebral endplates; but not equienergetic impact load, promotes disc degeneration in vitro. J. Orthop. Res. 2012;30:809–816. doi: 10.1002/jor.21573.
10. Effects of secreted factors inculture medium of annulus fibrosus cells on microvascular endothelial cells: Elucidating the possible pathomechanisms of matrixdegradation and nerve in-growth in disc degeneration / Moon H.J., Yurube T., Lozito T.P. [et al.] / Osteoarthr. Cartil. 2014;22:344–354. doi: 10.1016/j.joca.2013.12.008.
11. Wang S.L., Yu Y.L., Tang C.L. [et al.]. Effects of TGF-β1 and IL-1β on expression of ADAMTS enzymes and TIMP-3 in human intervertebral disc degeneration. Exp. Ther. Med. 2013;6:1522-1526. doi: 10.3892/etm.2013.1348.
12. Deng X., Zhao F., Kang B. [et al.]. Elevated interleukin-6 expression levels are associated with in-tervertebral disc degeneration. Exp. Ther. Med. 2016;11:1425–1432. doi: 10.3892/etm.2016.3079.
13. Klawitter M., Hakozaki M., Kobayashi H. [et al.]. Expression and regulation of toll-like receptors (TLRs) in human intervertebral disc cells. Eur. Spine J. 2014;23:1878–1891. doi: 10.1007/s00586-014-3442-4.
14. Liu X.W., Kang J., Fan X.D. [et al.]. Expression and significance of VEGF and p53 in rat degener-ated intervertebral disc tissues. Asian Pac. J. Trop. Med. 2013;6:404–406. doi: 10.1016/S1995-7645(13)60047-4.
15. Yamamoto J., Maeno K., Takada T. [et al.]. Fas ligand plays an important role for the production of pro-inflammatory cytokines in intervertebral disc nucleus pulposus cells. J. Orthop. Res. 2013;31:608–615. doi: 10.1002/jor.22274.
16. Gawri R., Rosenzweig D.H., Krock E. [et al.]. High mechanical strain of primary intervertebral disc cells promotes secretion of inflammatory factors associated with disc degeneration and pain. Arthritis Res. Ther. 2014;16:R21. doi: 10.1186/ar4449.
17. Shneider N.A., Ashhotov A.V., Trefilova V.V. [et al.]. High-Tech methods of cytokine imbalance correction in intervertebral disc degeneration. Int. J. Mol. Sci. 2023;24:13333. https://doi.org/10.3390/ijms241713333.
18. Studer R.K., Vo N., Sowa G. [et al.]. Human nucleus pulposus cells react to IL-6: Independent ac-tions and amplification of response to IL-1 and TNF-α. Spine 2011;36:593–599. doi: 10.1097/BRS.0b013e3181da38d5.
19. He W.S., Zou M.X., Yan Y.G. [et al.]. Interleukin-17A promotes human disc degeneration by inhib-iting autophagy through the activation of the phosphatidylinositol 3-kinase/Akt/Bcl2 signaling path-way. World Neurosurg. 2020;143:215-223. doi: 10.1016/j.wneu.2020.07.117.
20. Xue H., Yao Y., Wang, X. [et al.]. Interleukin-21 is associated with the pathogenesis of lumbar disc herniation. Iran J. Allergy Asthma Immunol. 2015;14:509–518.
21. Intervertebral disk degeneration and repair / Dowdell J., Erwin M., Choma T. [et al.] / Neurosurgery. 2017;80(3S):46-54. doi: 10.1093/neuros/nyw078.
22. Lin X., Lin Q., Ye J.-J. Role of IL-17 in Nucleus Pulposus Cell Proliferation and Metabolism Cul-tured In Vitro / Asian Pac. J. Trop. Med. 2015;8:41–47. doi: 10.1016/S1995-7645(14)60185-1.
23. Moen G.-H., Moen A., Schistad E.I. [et al.]. Local up-regulation of interferon-γ (IFN-γ) following disc herniation is involvedin the inflammatory response underlying acute lumbar radicular pain. Cy-tokine 2017;97:181–186. doi: 10.1016/j.cyto.2017.06.005.
24. Martinon F., Burns K., Tschopp J. The inflammasome: A molecular platform triggering activation of inflammatory caspases andprocessing of proIL-beta / Mol. Cell. 2002;10:417–426. doi: 10.1016/s1097-2765(02)00599-3.
25. Rigal J., Leglise A., Barnetche T. [et al.]. Meta-analysis of the effects of genetic polymorphisms on intervertebral disc degeneration. Eur. Spine J. 2017;26:2045–2052. doi: 10.1007/s00586-017-5146-z.
26. Molecular basic of pharmacotherapy of cytokine imbalance as a component of intervertebral disc de-generation treatment / Shnayder N.A., Ashkhotov A.V., Trefilova V.V. [et al.] / Int J Mol Sci. 2023;24(9):7692. doi: 10.3390/ijms24097692.
27. Murata Y., Onda A., Rydevik B. Changes in pain behavior and histologic changescaused by applica-tion of tumor necrosis factor-alpha to the dorsal root ganglion in rats / Spine 2006;31:530–535. doi: 10.1097/01.brs.0000201260.10082.23.
28. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs / Cardiovasc. Res. 2006;69:562–573. doi: 10.1016/j.cardiores.2005.12.002.
29. Lan T., Shiyu-Hu Shen Z., Yan B. [et al.] New insights into the interplay between miRNAs and au-tophagy in the aging ofintervertebral discs. Ageing Res. Rev. 2021;65:101227. doi: 10.1016/j.arr.2020.101227.
30. Ojala J.O., Sutinen E.M. The role of interleukin-18, oxidative stress and metabolic syndrome in Alz-heimer’s disease / J. Clin Med. 2017;6:55. doi: 10.3390/jcm6050055.
31. Xie J., Li B., Zhang P. [et al.]. Osteogenic protein-1 attenuates the inflammatory cytokine-induced NP cell senescence through regulating the ROS/NF-κB pathway. Biomed. Pharmacother. 2018; 99:431-437. doi: 10.1016/j.biopha.2018.01.053.
32. Zador F., Joca S., Nagy-Grocz G. [et al.]. Pro-inflammatory cytokines: potential links between the endocannabinoid system and the kynurenine pathway in depression. Int. J. Mol. Sci. 2021;22:5903. doi: 10.3390/ijms22115903.
33. Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-beta production in human neuron-like cells / Sutinen E.M., Pirttila T., Anderson G. [et al.] / J. Neuroinflamm. 2012;9: 199. doi: 10.1186/1742-2094-9-199.
34. Bai Z., Liu W., He D. [et al.]. Protective effects of autophagy and NFE2L2 on reactive oxygen spe-cies-induced pyroptosis of human nucleus pulposus cells. Aging. 2020;12(8):7534-7548. doi: 10.18632/aging.103109.
35. Adamczak S.E., de Rivero Vaccari J.P., Dale G. [et al.]. Pyroptotic neuronal cell death mediated by the AIM2 in-flammasome. J. Cereb. Blood Flow Metab. 2014;34:621–629. doi: 10.1038/jcbfm.2013.236.
36. Qazi B.S., Tang K., Qazi A. Recent advances in underlying pathologies provide insight into interleu-kin-8 expression-mediatedinfammation and angiogenesis / Int. J. Inflam. 2011;2011:908468. doi: 10.4061/2011/908468.
37. Weber K.T., Alipui D.O., Sison C.P. [et al.]. Serum levels of theproinflammatory cytokine interleu-kin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases. ArthritisRes. Ther. 2016;18:3. doi: 10.1186/s13075-015-0887-8.
38. Yang M., Peng Y., Liu W. [et al.] . Sirtuin 2 expression suppresses oxidative stress and senescence of nucleus pulposus cells through inhibition of the p53/p21 pathway. Biochem. Biophys. Res. Commun. 2019;513(3):616-622. doi: 10.1016/j.bbrc.2019.03.200.
39. Brown S., Rodrigues S., Sharp C. [et al.]. Staying connected: structural integration at the interverte-bral disc-vertebra interface of human lumbar spines. Eur Spine J. 2017;26(1):248–258. doi: 10.1007/s00586-016-4560-y.
40. Tchetina E.V., Markova G.A. Regulation of energy metabolism in the growth plate and osteoarthritic chondrocytes / Rheumatol. Int. 2018;386:1963–1974. doi: 10.1007/s00296-018-4103-4.
41. Nurgaliev Z.A., Shneider N.A, Trefilova V.V. [et al.]. The Frequency of Low Back Pain. Personal-ized Psychiatry and Neurology 2023;3(1):28-41. https://doi.org/10.52667/2712-9179-2023-3-1-28-41.
42. Li Y., Samartzis D., Campbell D.D. [et al.]. Two subtypes of intervertebral disc degeneration distin-guished by large-scale population-based study. Spine J. 2016;(9):1079-89. doi: 10.1016/j.spinee.2016.04.020.
43. Harper E.G., Guo C., Rizzo H. [et al.]. Th17 cytokinesstimulate CCL20 expression in keratinocytes in vitro and in vivo: Implications for psoriasis pathogenesis. J. Invest. Dermatol. 2009;129:2175–2183. doi: 10.1038/jid.2009.65.
44. Wang H., Ding W., Yang D. Different concentrations of 17β-estradiol modulates apoptosis induced by interleukin-1β in rat annulus fibrosus cells / Mol. Med. Rep. 2014;10:2745–2751. doi: 10.3892/mmr.2014.2514
45.
Review
For citations:
Ashkhotov A.V., Shnaider N.A., Trefilova V.V., Novitsky M.A., Petrova M.M., Nasyrova R.F. The role of proinflammatory cytokines in the development of chronic discogenic pain syndrome. Yakut Medical Journal. 2023;(4):128-134. https://doi.org/10.25789/YMJ.2023.84.30
Views:
24
Email this article 